Verition Fund Management LLC
Institutional investor · Portfolio as of Q4 2019
Top Holdings1,035 positions
Facebook Inc | 1.5M | $301.9M | 5.5% | $203.00 | +0.15% | 5 qtrssince 2018-Q4 | Increased 97 |
Facebook Inc | 1.5M | $297.6M | 5.4% | — | — | — | New — |
Allergan PLC | 1.6M | $296.6M | 5.4% | — | — | — | Increased — |
Microsoft Corp | 1.3M | $199M | 3.6% | $148.32 | +0.32% | 5 qtrssince 2018-Q4 | Increased 90 |
Microsoft Corp | 1.3M | $197.1M | 3.6% | — | — | — | New — |
SPDR GOLD TRUST GOLD SHS | 800,000 | $114.3M | 2.1% | — | — | — | New — |
Tiffany & Co | 808,700 | $108.1M | 2.0% | — | — | — | New — |
SPDR S&P 500 ETF Trust | 320,100 | $103M | 1.9% | — | — | — | Increased — |
Amazon.com Inc | 52,690 | $97.4M | 1.8% | $91.85 | +0.59% | 5 qtrssince 2018-Q4 | Increased 76 |
| 50M | $96.3M | 1.8% | — | — | — | New 68 | |
Invesco QQQ Trust Series 1 | 450,000 | $95.7M | 1.7% | $204.20 | +0.28% | 2 qtrssince 2019-Q3 | Increased 76 |
Invesco QQQ Trust Series 1 | 450,000 | $95.7M | 1.7% | — | — | — | Increased — |
Amazon.com Inc | 50,000 | $92.4M | 1.7% | — | — | — | New — |
MELLANOX TECHNOLOGIES LTD | 701,100 | $82.2M | 1.5% | — | — | — | Increased — |
SPDR S&P 500 ETF Trust | 225,501 | $72.6M | 1.3% | $291.06 | +0.55% | 2 qtrssince 2019-Q3 | Increased 75 |
Allergan PLC | 370,600 | $70.8M | 1.3% | — | — | — | Decreased — |
Bristol-Myers Squibb Co | 1.1M | $67.1M | 1.2% | — | — | — | Increased — |
NVIDIA Corp | 271,355 | $63.9M | 1.2% | $5.67 | +3.14% | 3 qtrssince 2019-Q2 | Increased 75 |
| 23.5M | $59.6M | 1.1% | — | — | — | Increased 61 | |
Berkshire Hathaway Inc | 259,796 | $58.8M | 1.1% | $220.75 | +2.60% | 4 qtrssince 2019-Q1 | Increased 75 |
Verition Fund Management LLC manages $5.5B across 1035 positions as of Q4 2019. Top holdings: META (5.5%), META puts (5.4%), AGN puts (5.4%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
Active quarter - 442 new positions, 420 exits, 215 increased. Top move: META (INCREASED, conviction 97). Portfolio: $5.5B across 1035 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR